← Back to Search

Long Peripheral Catheter for Vascular Access Complications (ComPLET Trial)

N/A
Waitlist Available
Led By Alina Burek
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Peripherally compatible infusate
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through the study completion, an average of 1 year
Awards & highlights

ComPLET Trial Summary

This trial is testing whether long peripheral catheters (LPCs) are a safer alternative to peripherally inserted central catheters (PICCs) for medium-term vascular access in hospitalized pediatric patients.

ComPLET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
The treatment can be given through a vein in your arm.

ComPLET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through the study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through the study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average dwell-time
Number of feasibility measures accomplished
Secondary outcome measures
Average time-to-placement of VAD
Percent VADs successfully used for blood draws
Percent completion of therapy with initial VAD
+4 more

ComPLET Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Long Peripheral CatheterExperimental Treatment1 Intervention
Group II: Peripherally Inserted Central CatheterActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Long Peripheral Catheter
2023
N/A
~310

Find a Location

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
604 Previous Clinical Trials
1,162,248 Total Patients Enrolled
Alina BurekPrincipal InvestigatorMedical College of Wisconsin

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the research protocol exclude participants who are younger than sixty?

"In keeping with the trial's prerequisites, potential participants must be between 2 and 17 years old."

Answered by AI

Who fulfills the eligibility criteria for participation in this trial?

"This trial is open to 60 children aged 2-17 who are currently struggling with vascular access device issues. It is a prerequisite for them to have an intravenous treatment that will last between 5 and 14 days, use peripherally compatible infusates, and not require VADs at discharge."

Answered by AI

What is the goal of this experiment?

"This study will assess the Average dwell-time over a 12-month period as its primary outcome. Other metrics being observed are the Percent participants with prolonged NPO (nothing by mouth) time, the success rate of VADs for blood draws, number of attempted and successful blood draw attempts through catheterization, and finally, Average time-to-placement of VAD."

Answered by AI

To what extent is this trial being participated in by subjects?

"Indeed, the clinicaltrials.gov data confirms that recruitment for this medical study is ongoing. It was launched on August 1st 2022 and amended most recently on August 10th 2022. The trial has a target of 60 patients at one location."

Answered by AI

Is enrollment in this research study still open?

"Affirmative. Information available on clinicaltrials.gov indicates that the trial, which was initially posted on August 1st 2022, is actively recruiting patients. Currently, 60 participants are needed at a single medical centre."

Answered by AI
Recent research and studies
~3 spots leftby Mar 2025